Product and service innovation is a complex environment to navigate, with processes becoming more advanced and the market more disruptive. The Enterprise Hub can support you to stay relevant and competitive by integrating interdisciplinary research and cutting-edge strategies into your existing business operations. 

We can test new ways to transform your existing supply chain, processes or techniques through automation and nanotechnology, leading to increased efficiency or optimised product life cycles. Projects can be tailored to your requirements, and include identifying new product opportunities, adding value to existing products, research and validation.

We have an extensive network of industry partners, and can leverage their expertise when collaborating with you, giving you a competitive edge. We’ll work with you in our specialist facilities to trial, explore and integrate new technology, creating opportunities for your business to innovate and thrive.  

Contact us

A researcher examining materials

Evolve current practice to create or improve products


Address unique challenges

Access leading edge design and advanced technologies


Build market resilience

Increase business capability and growth in local and global markets


Create a relative advantage

Enhance sustainability, productivity and profitability


Innovation opportunities

Take advantage of advanced manufacturing and Industry 4.0 technologies

Case studies

Better cancer detection for more precise treatment

In partnership with medical device company, Ferronova, researchers from UniSA’s Future Industries Institute (FII), Dr Aidan Cousins and Professor Benjamin Thierry, have developed a biodiagnostic system to refine cancer detection. The system consists of a magnetic probe and injectable magnetic nanoscale tracers, able to detect the spread of cancer less invasively, more quickly, and more accurately than existing methods. It delivers an accurate and affordable system for the staging of deep or complex cancers, such as head and neck, gastrointestinal and oesophageal cancers.

Read more

“Translating university IP into human trials is a significant undertaking, and the Ferronova nanoparticle technology is one of the first new magnetic nanoparticle technologies to be translated to the clinic in over 20 years... The collaboration has been positive for both UniSA and Ferronova.”

Stewart Bartlett, CEO, Ferronova

Related services

Key Contacts

Esther Roberts
Deputy Director: Business Development, Enterprise Partnerships Unit

Contact the Enterprise Hub

Get in touch with us to find out how we can support your business needs.

Make an enquiry online or call us to discuss your idea